glp-1 moa Frontiers Frontiers | The agony and

These effects are why medications like Ozempic (semaglutide), Wegovy (semaglutide at a higher dose), and Mounjaro (tirzepatide) are effective at reducing appetite and supporting weight loss

We have noticed a similar upward trend in utilization and spend for GLP-1s across our book of business, with plan drug spend for Wegovy alone increasing over 500% between 2022 and 2023

The hazard ratio for the first year after starting treatment was 1.47 (0.74 to 2.93)

49 The evolution of research starting from the first SUSTAIN trial to the creation of the new oral form of semaglutide 5055 is depicted in Figure 3

doi: 10.1002/jnr.22565 74 PellecchiaMTPivonelloRLongoKManfrediMTessitoreAAmboniMet al